Otsuka Pharmaceutical To Acquire Jnana Therapeutics
01/08/2024 05:03
Aug 1 (Reuters) - Otsuka Holdings Co Ltd 4578.T :
* OTSUKA HOLDINGS CO LTD - OTSUKA PHARMACEUTICAL TO ACQUIRE
JNANA
THERAPEUTICS
* OTSUKA HOLDINGS CO LTD - OTSUKA WILL PAY USD $800 MILLION
TO THE
SHAREHOLDERS OF JNANA UPON COMPLETION OF THE ACQUISITION, AS
WELL AS UP TO AN ADDITIONAL USD $325 MILLION IN DEVELOPMENT AND
REGULATORY MILESTONES
* OTSUKA HOLDINGS CO LTD - AIM TO COMPLETE THE ACQUISITION
DURING
THE THIRD QUARTER OF 2024
Source text for Eikon: ID:nTSta88ce4
Further company coverage: 4578.T
((Satoshi.Sugiyama@thomsonreuters.com;))
Recent news on Otsuka Holdings
See all newsOtsuka, Ionis' experimental ALS drug meets main goal in late-stage study
Brief: Otsuka Pharmaceutical Announces Ulefnersen Early Access Program For Eligible People Living With FUS-ALS
Brief: Otsuka Pharmaceutical Says Phase 3 Fusion Results For Ulefnersen Met Primary Endpoint
Zipalertinib Plus Chemotherapy Demonstrates 6-Month Median Progression-Free Survival Benefit In Rezilient3 Phase 3 Trial In First-Line Egfr Exon 20 Insertion Mutation Non-Small Cell Lung Cancer
Climb Bio rises after early-stage data for kidney disease drug